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Abstract:  Marine  microalgae  constitute  a  natural  source  of  a  variety  of  drugs  for 
pharmaceutical,  food  and  cosmetic  applications—which  encompass  carotenoids,  among 
others. A growing body of experimental evidence has confirmed that these compounds can 
play  important  roles  in  prevention  (and  even  treatment)  of  human  diseases  and  health 
conditions,  e.g.,  cancer,  cardiovascular  problems,  atherosclerosis,  rheumatoid  arthritis, 
muscular dystrophy, cataracts and some neurological disorders. The underlying features 
that may account for such favorable biological  activities are their intrinsic antioxidant,  
anti-inflammatory  and  antitumoral  features.  In  this  invited  review,  the  most  important 
issues regarding synthesis of carotenoids by microalgae are described and discussed—from 
both physiological and processing points of view. Current gaps of knowledge, as well as 
technological opportunities in the near future relating to this growing field of interest, are 
also put forward in a critical manner.  
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1. Introduction 
Microalgae occupy the bottom of the food chain in aquatic ecosystems; they possess the intrinsic 
ability to take up H2O and CO2—which, with the aid of sunlight, are converted to complex organic 
compounds that are subsequently kept inside or released from the cell. Those microorganisms have a 
worldwide  distribution,  and  are  well-adapted  to  survive  under  a  large  spectrum  of  environmental 
stresses—including (but not limited to) heat, cold, drought, salinity, photo-oxidation, anaerobiosis, 
osmotic pressure and UV exposure [1].  
Microalgae combine, in a balanced way, a few properties typical of higher plants (viz. efficient 
oxygenic photosynthesis and simple nutritional requirements) with biotechnological attributes proper 
of microorganisms (viz. fast growth rates, and ability to accumulate or secrete primary and secondary 
metabolites). This rather useful combination has led to selection of such microorganisms for applied 
processes, and represents the basic rationale for the usefulness of microalgal biotechnology. Besides 
being currently used as feed for aquatic and terrestrial animals, the nutritional value of microalgal 
biomass  goes  well  beyond—and  includes  use  as  colorant  in  aquaculture,  and  high-protein  or 
polyunsaturated fatty acid supplement in human diets. The food, pharmaceutical and cosmetic markets 
have accordingly benefited from a growing array of microalgal products [2,3].  
Furthermore, the large number of existing species of microalgae constitutes a unique reservoir of 
biodiversity,  which  supports  potential  commercial  exploitation  of  many  novel  products  besides 
vitamins, pigments and polyunsaturated fatty acids [4–6]. The key factor for their eventual economic 
feasibility is the possibility of operating large photobioreactors, able to handle biomass and metabolites 
to sufficiently high levels [7,8]. 
This  review  covers  the  most  relevant  features  of  a  family  of  specialty  products  originated  in 
microalgae  that  have  already  reached  commercial  expression—by  presenting  bioprocess 
considerations and reviewing practical applications, mainly in the food and health industries. 
2. Cellular Location and Function 
Carotenoids  constitute  a  class  of  terpenoid  pigments,  derived  from  a  40-carbon  polyene  
chain,  which  can  be  envisaged  as  their  molecular  backbone—indeed  it  provides  carotenoids  with 
distinctive  molecular  structures,  and  the  associated  chemical  properties  including  light-absorption 
features that are essential for photosynthesis and, in general, for life in the presence of oxygen [9]. The 
aforementioned  backbone  may  be  complemented  by  cyclic  groups  (rings)  and  oxygen-containing 
functional  groups.  Hence,  hydrocarbon  carotenoids  are  denoted  as  carotenes  as  a  whole,  but 
oxygenated derivatives are known specifically as xanthophylls—with oxygen being present as –OH 
groups (e.g., lutein), as oxi-groups (e.g., cantaxanthin) or as a combination of both (e.g., astaxanthin) [9]. 
All  xanthophylls  synthesized  by  higher  plants—e.g.,  violaxanthin,  antheraxanthin,  zeaxanthin, 
neoxanthin and lutein, can also be synthesized by green microalgae; however, these possess additional 
xanthophylls,  e.g.,  loroxanthin,  astaxanthin  and  canthaxanthin.  Diatoxanthin,  diadinoxanthin  and 
fucoxanthin can also be produced by brown algae or diatoms [10]. 
A  distinction  is  usually  made  between  primary  and  secondary  carotenoids:  primary  ones  
(i.e., xanthophylls) are structural and functional components of the cellular photosynthetic apparatus, Mar. Drugs 2011, 9                             
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so they are essential for survival [10]; whereas secondary ones encompass those produced by microalgae 
to large levels, but only after exposure to specific environmental stimuli (via carotenogenesis). 
Xanthophylls  are  relatively  hydrophobic  molecules,  so  they  are  typically  associated  with 
membranes and/or involved in non-covalent binding to specific proteins; they are usually localized in 
the thylakoid membrane, whereas secondary carotenoids are found in lipid vesicles—in either the 
plastid stroma or the cytosol. Most xanthophylls in cyanobacteria and oxygenic photosynthetic bacteria 
are associated with chlorophyll-binding polypeptides of the photosynthetic apparatus [11]; however, in 
most green microalgae, carotenes and xanthophylls are synthesized within plastids, and accumulate 
therein  only.  Conversely,  secondary  xanthophylls  in  some  green  microalgae—e.g.,  astaxanthin  in 
Haematococcus  sp.,  accumulate  in  the  cytoplasm;  this  realization  raises  the  possibility  of  an  
extra-plastidic site of carotenoid biosynthesis in that genus. Alternatively, xanthophylls synthesized in 
the chloroplast may be exported, and consequently accumulate in the cytoplasm [10,12,13]—so they 
may be found in essentially all cellular compartments. 
Carotenoids perform several functions in microalgae: they are involved in light harvesting, but also 
contribute  to  stabilize  the  structure  and  aid  in  the  function  of  photosynthetic  complexes—besides 
quenching  chlorophyll  triplet  states,  scavenging  reactive  oxygen  species  and  dissipating  excess  
energy [14]. The intrinsic antioxidant activity of carotenoids constitutes the basis for their protective 
action against oxidative stress; however, not all biological activities claimed for carotenoids relate to 
their ability to inactivate free radicals and reactive oxygen species. 
3. Practical Applications  
Several researchers have actively focused on carotenoids from microalgal sources; the major areas, 
in  terms  of  actual  or  potential  industrial  applications,  are  food  and  health—and  the  antioxidant 
properties exhibited by that class of compounds constitutes at present its core interest. Pigments of 
microalgal origin are indeed experiencing a strong market demand: the price of microalgal β-carotene 
easily attains 700 €/kg, whereas its synthetic counterpart cannot reach more than half that figure. 
Natural  β-carotene  is  preferred  by  the  health  market  because  it  is  a  mixture  of  trans  and  cis  
isomers—the latter of which possess anticancer features; such a mixture can hardly be obtained via 
chemical synthesis [14]. 
3.1. Uses for Food and Feed Formulation 
Manufacture  of  carotenoids  via  microbiological  routes  has  undergone  a  greater  and  greater 
scientific and commercial importance within the alimentary and aquaculture fields [15], especially in 
view of environmental and health awareness by consumers at large.  
Recall  that  most  oxidation  reactions  in  foods  are  deleterious—e.g.,  degradation  of  vitamins, 
pigments and lipids, with consequent loss of nutritional value and development of off-flavors [16,17]. 
Antioxidants—which are adventitious in, or deliberately added to foods, can inhibit oxidation or slow 
down initiation by free alkyl radicals, as well as interrupt propagation of such free radical chains. The 
threshold  of  synthetic  food  additives  legally  permitted  has  been  steadily  decreasing,  due  to  their 
suspected role as promoters of carcinogenesis, besides claims of liver and renal toxicities [18]; hence, 
substitution  thereof  by  natural  pigments  has  become  common  practice.  One  good  example  is  the Mar. Drugs 2011, 9                             
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application of Dunaliella spp. for mass production of carotenoids aimed at a preservation role [19,20]. 
Another advantage of carotenoids is that they are not affected by the presence of ascorbic acid, often 
used as acidulant to constrain unwanted microbial growth, nor by heating/freezing cycles employed in 
foods with a similar goal. 
On the other hand, carotenoids are particularly strong dyes, even at levels of parts per million. 
Specifically,  canthaxanthin,  astaxanthin  and  lutein  from  Chlorella  have  been  in  regular  use  as 
pigments, and have accordingly been included as ingredients of feed for salmonid fish and trout, as 
well as poultry—to enhance the reddish color of said fish or the yellowish color of egg yolk [4,21–23]. 
Furthermore,  β-carotene  has  experienced  an  increasing  demand  as  pro-vitamin  A  (retinol)  in 
multivitamin preparations; it is usually included in the formulation of healthy foods, although only 
under antioxidant claims [24–26].  
3.2. Uses for Health and Well-Being Promotion 
In the human being, oxidation  reactions  driven by reactive oxygen species can lead to  protein 
damage and DNA decay or mutation; these may in turn lead to several syndromes, viz. cardiovascular 
diseases,  some  kinds  of  cancer  and  degenerative  diseases,  and  ageing  at  large  [17,27].  As  potent 
biological antioxidants, carotenoids are able to absorb the excitation energy of singlet oxygen radicals 
into their complex ringed chain—thus promoting energy dissipation, while protecting tissues from 
chemical  damage.  They  can  also  delay  propagation  of  such  chain  reactions  as  those  initiated  by 
degradation of polyunsaturated fatty acids—which are known to dramatically contribute to the decay 
of lipid membranes, thus seriously hampering cell integrity [21].  
One  illustrative  example  is  the  decline  of  cognitive  ability  accompanying  Alzheimer’s  disease, 
which is apparently caused by persistent oxidative stress in the brain [28]. Using transgenic mice fed 
with  extracts  from  Chlorella  sp.  containing  β-carotene  and  lutein,  Nakashima  et  al.  [29]  claimed 
significant prevention of cognitive impairment. Wu et al. [30] used also Chlorella extracts containing 
2–4 mg/gDW of lutein, and reported reduction in the incidence of cancer, as well as prevention of 
macular degeneration [31]. Likewise, carotenoids extracted specifically from Chlorella ellipsoidea and 
Chlorella vulgaris inhibited colon cancer development [23]. Furthermore, astaxanthin obtained from 
Haematococcus pluvialis decreased expression of cyclin D1, but increased that of p53 and some cyclin 
kinase inhibitors of colon cancer cell lines [32]. 
Carotenoids have also the ability to stimulate the immune-system, thus being potentially involved in 
more than 60 life-threatening diseases—including various form of cancer, coronary heart diseases, 
premature ageing and arthritis [33]; this is specifically the case of canthaxanthin and astaxanthin, and 
other nonprovitamin A carotenoids from Chlorella but to a lesser degree [23]. A few epidemiological 
studies encompassing β-carotene from Dunalliela sp.—which contains readily bioavailable 9-cis and 
all-trans stereoisomers (ca. 40% and 50%, respectively), have indeed provided evidence of a lower 
incidence of several types of cancer and degenerative diseases [34]. Finally, carotenoids exhibited 
hyperlipidemic and hypercholesterolemic effects [19]. 
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4. Industrial Production 
The worldwide demand for carotenoids was ca. 640 M€ in 2004, but it has been rising ever since at 
an average yearly rate of 2.2% [9]; β-carotene has specifically risen from ca. 175 M€ in 2004 to  
ca.  183  M€  in  2009  [35].  A  growing  fraction  has  been  accounted  for  by  carotenoids  from 
biotechnological sources; and β-carotene, as well as such xanthophylls as astaxanthin, cantaxanthin 
and  lutein  have  consequently  been  in  higher  and  higher  demand  [9].  The  most  famous  source 
microalgae are Chlorella, Chlamydomonas, Dunaliella, Muriellopsis and Haematococcus spp.—all of 
which belong to the Chlorophyceae family [2]. They tend to accumulate carotenoids as an intrinsic part 
of their biomass, thus offering economical alternatives to chemical synthesis [36]. 
Among  all  natural  sources  studied  to  date,  Dunaliella  possesses  the  highest  content  of  9-cis  
β-carotene [20,34]—reaching levels up to 100 g/kgDW, [19,37,38]; β-carotene-rich Dunaliella powder 
has been commercially exploited in many countries since the 1980s. Although many microalgae can 
produce  xanthophylls,  H.  pluvialis  is  the  one  that  accumulates  them  to  the  highest  levels  
(e.g., asthaxanthin [10]), so it is now cultivated at large scale by several companies using distinct 
approaches [39]. On the other hand, Muriellopsis sp. holds a high lutein content (up to 35 mg L
−1), 
coupled with a high growth rate; hence, it has been exploited for commercial production of lutein [10]. 
Finally,  C.  ellipsoidea  was  reported  to  produce  violaxanthin,  together  with  two  other  minor 
xanthophylls, viz. antheraxanthin and zeaxanthin—whereas the main carotenoid in C. vulgaris was  
lutein [23]. Further pieces of related information are gathered in Table 1. 
Table 1. Carotenoids produced by selected microalgae. 
Microalga source  Active compound  Reference 
Dunaliella salina  β-carotene  [13,14] 
Haematococcus pluvialis  Astaxanthin, cantaxanthin, lutein  [14,18] 
Chlorella vulgaris  Cantaxanthin,  astaxanthin  [14,19] 
Coelastrella striolata var. 
multistriata 
Canthaxanthin, astaxanthin, β-carotene  [40] 
Scenedesmus almeriensis  Lutein, β-carotene  [41] 
5. Biotechnological Processes 
Despite a few useful features already referred to above, microalgae are in general expensive to  
produce,  so  concerted  efforts  have  been  on  the  way  toward  more  cost-efficient  modes  of  
mass cultivation.  
With regard to open systems, the best choice seems to be the open shallow pond—made of leveled 
raceways, 2–10 m wide and 15–30 cm deep, which run as simple loops or meandering pathways; each 
unit may cover an area of several hundred to a few thousand m
2. However, this configuration poses 
several  problems—which  restrict  its  use  to  strains  that,  in  view  of  their  weed-like  behavior 
(e.g., Chlorella) or their ability to withstand adverse growing conditions (e.g., Spirulina or Dunaliella), 
can outgrow other microorganisms.  Mar. Drugs 2011, 9                             
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Table 2. Optimal conditions of production of carotenoids by selected microalgae. 
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Microalga 
source  
Processing conditions 
Reactor 
configuration 
Productivity  Ref 
β
-
c
a
r
o
t
e
n
e
 
Dunaliella 
salina 
T: 25 ° C; pH: 7.5 ±  0.5;  
LI: 281 ±  89 µ molphoton m
−2 s
−1;  
SR: 38 cms
−1 s
−1  
Semi-continuous 
outdoor, closed 
tubular (55 L) 
Biomass: 2 g m
−2 d
−1  
Total carotenoids: 102.5 ±  33.1 mg m
−2 d
−1 
(β-carotene: 10% of biomass) 
[42] 
T: 30 ° C; pH: 7.5; 
LI: 200–1200 μmolphoton m
−2 s
−1; 
SR: 0.6 L min
−1 (N2) 
Continuous 
turbidostat,  
flat-panel (2.5 L) 
β-Carotene: 13.5 mg L
−1 d
−1  
(15.0 pg cell
−1) 
[43] 
T: 30 ° C; pH: 7.5; 
LI: 200–1200 μmolphoton m
−2 s
−1; 
SR: 0.286 Lsolvent L
−1 min
−1 (organic 
solvent)  
Continuous 
turbidostat,  
flat-panel (1.9 L) 
with in situ 
extraction 
β-Carotene: 0.7 mg  L
−1 d
−1 
β-Carotene: 8.3 mg L
−1 d
−1 
(8.9 pg cell
−1) 
L
u
t
e
i
n
 
Muriellopsis sp. 
T: 28 ° C; pH 6.5; 
LI: 460 μmolphoton m
−2 s
−1 
Batch (0.2 L,  
4–7 d) 
Lutein content: 5.5 mg g
−1 L
−1 d
−1 
Lutein: 0.8–1.4 mg L
−1 d
−1 
[44] 
T: 28 ° C; pH: 7;  
LI: continuous 200 μmolphoton m
−2 s
−1;  
AF: 50–100 L
−1 h
−1 (1 %, v/v CO2) 
Continuous 
outdoor, tubular (55 
L) 
Biomass: 7.2 mg L
−1 d
−1  
Lutein: 5.5 mg g
−1 L
−1 d
−1 
[44] 
- 
Semicontinuous 
outdoor, open tank 
(100 L) 
Biomass: 100 mg m
−2 d
−1 
Lutein: 100 mg g
−1 L
−1 d
−1 
[42] 
Scenedesmus 
almeriensis 
T: 30 ° C; pH: 8.0;  
LImax: 1700 μE m
−2 s
−1;  
AF: 0.5 (v/v)/min
−2 s
−1;  
LDC: solar cycle 
Continuous (2 L)  Lutein: 4.9 mg L
−1 d
−1  [8] 
T: 35 ° C; LI: 1900 μE m
−2 s
−1 
Continuous 
outdoor, tubular  
Lutein: 5.31 mg m
−2 d 
−1  [45] 
Chlorella 
protothecoides 
T: 28 ° C; pH: 6.5;  
LI: absence of light;  
MM: heterotrophic 
Batch (16 L)  Lutein: 10 mg L
−1 d
−1  [46] 
Chlorella 
zofingiensis  T: 28 ° C; pH: 7;  
LI: 200 μmolphoton m
−2 s
−1;  
AF: 50–100 L
−1 h
−1 (1%, v/v CO2) 
LDC: continuous light 
Batch (0.2 L) 
Lutein: 3.4 mg L
−1 d
−1 
[44] 
Chlorococcum 
citriforme 
Lutein: 1.05 mg L
−1 h
−1 
Neospongiococc
us gelatinosum 
Lutein: 0.70 mg L
−1 h
−1 Mar. Drugs 2011, 9                             
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Table 2. Cont. 
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Microalga 
source 
Processing conditions  Reactor configuration  Productivity  Ref 
A
s
t
a
x
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n
t
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C. zofingiensis 
T: 30 ° C; pH: 6.5; LI: darkness;  
SR: 130 rpm; MM: heterothrophic 
Batch (250 mL)  Astaxanthin:10.3 mg L
−1  [47] 
Haematococcu
s pluvialis 
LI: day light cycle  
Continuous chemostat, 
tubular (50 L)  
Biomass: 0.7 g L
−1d
−1 
Astaxanthin: 8.0 mg L
−1d
−1 
[48] 
T: 28 ° C; LI: 345 µ molphoton m
−2 s
−1  Batch (1 L)   Astaxanthin content: 98 mg g
−1
biomass  [49] 
T: 15–25 ° C;  
LImax: 2000 µ molphoton m
−2 s
−1 
Enclosed outdoor 
(25,000 L)  
Biomass: 90 g m
−2 
Astaxanthin: 13 g m
−2 d
−1 
[39] 
AF: air flow; LDC: light/dark cycle; LI: light irradiance; MM: metabolic mode; SR: stirring rate; T: temperature. 
More advanced technologies have meanwhile been made available pertaining to closed systems; 
these provide better options for growth of most microalgal strains, by protecting the culture from 
contamination by unwanted (and often ill-defined) microorganisms, and allowing comprehensive and 
integrated control of processing conditions. Such photobioreactors are either flat or tubular, and may 
adopt a variety of designs and operation modes. They lead to higher volumetric productivities and an 
overall better quality for the biomass (or product) generated—but they are also more expensive to 
build and operate than their open counterparts [9]. 
Some microalgae exhibit unique productivity and plasticity features: when grown under distinct sets 
of operating conditions, they may accumulate different products to high levels; hence, careful design 
and  control  of  medium  composition,  temperature,  pH,  aeration,  stirring  and  irradiance  are 
recommended. A few examples of optimum conditions of operation of microalgal reactors—using 
productivity of carotenoids as objective function, are listed in Table 2. 
During  microalgal  cultivation,  a  few  processing  parameters  can  be  specifically  manipulated  for 
maximum synthesis of carotenoids; the better studied cases are lutein, astaxanthin and β-carotene—which 
will be discussed below at some length. 
5.1. Lutein 
The most important factors that affect lutein content in microalgae are temperature, irradiance, pH, 
availability and source of nitrogen, salinity (or ionic strength) and presence of oxidizing substances (or 
redox potential); however, specific growth rate also plays a crucial role. 
High temperature favors accumulation of lutein, as happens with other carotenoids (e.g., β-carotene) 
in Dunaliella sp. [42], close to the limit of environmental stress; further temperature increases would 
thus be harmful, and eventually reduce biomass productivity.  
A high irradiance level appears beneficial—but its effect depends on whether indoor or outdoor 
cultivation is considered; in vitro mimicking of all parameters that characterize outdoor operation, e.g., 
solar cycle and temperature fluctuation, is indeed difficult. Furthermore, the concentration of molecular 
oxygen outdoors cannot be manipulated, despite its interacting with illumination and temperature. Both 
irradiance and temperature influence the rate of lutein production, yet cultures of Murielopsis sp. and Mar. Drugs 2011, 9                             
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Scenedesmus almeriensis produced contradictory results; hence, these two factors should be considered in a 
combined, rather than independent fashion [8]. 
Likewise, the reported effects of pH are not consistent between batch and continuous cultivations. 
In the former, lutein content increased at extreme pH values, whereas the best results under continuous 
operation were observed at the optimum pH for growth rate. It is worth noting that pH is particularly 
relevant  in  microalgal  cultures  because  it  interferes  with  CO2  availability  (which  is  essential  for 
photosynthesis);  hence,  continuous  supply  of  CO2,  as  a  fraction  of  the  aeration  stream,  and  
pH-controlled  injection  lead  to  different  results.  In  general,  the  maximum  lutein  productivity  is 
achieved at the optimum pH for biomass productivity [45]. 
The concentration of nitrogen in the culture medium (in the form of nitrate) does not apparently 
cause a significant effect upon the lutein content of biomass; however, N-limitation reduces biomass 
productivity, and consequently leads to poor overall lutein synthesis. Hence, nitrate should be supplied 
to  a  moderate  excess—so  that  growth  rate  is  not  hampered,  while  avoiding  saline  stress  that 
dramatically affects culture performance [8].  
Lutein synthesis is enhanced via addition of such chemicals as H2O2 and NaClO, which behave as 
inducers: in the presence of Fe
2+, they affect the redox state and generate stress-inducing chemical 
species. This induction of oxidative stress is expected because lutein holds a protection role conveyed 
by  its  antioxidant  features—particularly  under  heterotrophic  growth,  where  spontaneous  oxidative 
stress is normally absent (unlike happens with phototrophic cultures)
 [45].  
Finally, the specific growth rate affects both continuous and semicontinuous cultures: lutein tends 
to accumulate at low dilution rates, but not to levels sufficient to balance the decrease in biomass 
productivity under such circumstances. Therefore, the maximum lutein productivity is again typically 
attained at the optimal dilution rate for biomass production [45]. 
5.2. Astaxanthin  
Commercial production of astaxanthin by Haematococcus sp. has been implemented by more than 
one  microalga  company  (e.g.,  Cyanotech  and  Aquasearch);  they  resorted  to  a  two-stage  system, 
consisting of a first step to produce green biomass under optimal growth conditions (―green‖ stage), 
followed by a second stage when the microalga is exposed to adverse environmental conditions to 
induce  accumulation  of  astaxanthin  (―red‖  stage)
  [50].  Astaxanthin  productivities  in  large  scale 
facilities  are  typically  ca.  2.2  mg  L
−1  [39]—even  though  maximum  astaxanthin  productivities  of  
11.5 mg L
−1 d
−1 can be attained
 at bench scale [51].  
Micro  Gaia,  a  marine  biotech  firm  engaged  in  production  of  microalgae  rich  in  astaxanthin, 
proposed a single-step, continuous manufacture process using moderate nitrogen limitation [52,53]: 
the biomass and astaxanthin productivities obtained were 8.0 and 0.7 mg L
−1d
−1, respectively [54]. The 
feasibility  of  the  latter  approach  for  production  of  astaxanthin  by  H.  pluvialis  was  tested  
continuous-wise in outdoor apparatuses [48]: Aquasearch Growth Modules (AGM)—i.e., 25,000 L 
enclosed, computerized photobioreactors, were combined up to three units to obtain large amounts of 
clean,  fast  growing  H.  pluvialis;  they  were  transferred  daily  to  a  pond  culture  system,  where 
carotenogenesis and astaxanthin accumulation were induced. After 5 days of synthesis, cells were 
harvested  by  gravitational  settling—with  a  typical  content  of  2.5%  (w/wDW)  astaxanthin;  a  high 
pressure homogenizer was  used to  disrupt  the cells,  and then drying was  carried out  to  less than  Mar. Drugs 2011, 9                             
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5% (w/w) moisture. The performance of AGM could be improved 2-fold within the first 9 mo of 
operation; and the biomass concentration increased from 50 to 90 g m
−2, with associated productivities 
increasing from 9 to 13 g m
−2 d
−1 within the same period
 [39]. 
However, the production capacity of H. pluvialis was constrained by its intrinsic slow growth, low 
cell  yield,  ease  of  contamination  by  bacteria  and  protozoa,  and  susceptibility  to  adverse  weather 
conditions [5]. Moreover, H. pluvialis cannot be efficiently cultivated in dark heterotrophic mode—so 
production of astaxanthin should adopt the photosynthetic mode, and thus resort to levels of irradiance 
(e.g., 950 µmol m
−2 s
−1) well beyond what would be economically reasonable [39]. Owing to its ease 
of  culturing  and  high  tolerance  to  environmental  fluctuations,  C.  zofingiensis  (another  green 
microalga)  has  been  put  forward  as  an  alternative  for  astaxanthin  production:  it  grows  quite  fast 
(ca. three  times  faster  than  H.  pluvialis),  and  accumulates  significant  amounts  of  secondary 
carotenoids in the dark, thus facilitating large-scale cultivation of denser biomass [47,55].  
Oxidative  stress  induced  by  intense  illumination  has  been  found  to  play  a  crucial  role  upon 
astaxanthin synthesis [56]; active oxygen molecules, generated by excess photooxidation caused by 
high light irradiance, do apparently trigger synthesis of carotenoids as part of a cellular strategy aimed 
at  cell protection against oxidative damage [47].  In particular, flashing  light  increased the rate of 
astaxanthin production per photon in H. pluvialis by at least 4-fold relative to that under continuous 
light sources [57]—thus proving that light quality is more important than quantity [58].  
The effect of irradiance depends also on such operating variables as culture density, cell maturity 
(flagellates are much more sensitive than palmelloids), medium nutrient profile and light path
 [59]. 
The predominant role of light stress and nitrogen deprivation towards induction and enhancement of 
biosynthesis in the aplanospores of H. pluvialis was originally suggested in the 1950s [60]; astaxanthin 
accumulation comes along with  growth halting, as happens in most cases of stress imposed upon  
microalgae
 [59,61]. Imamoglu et al. [54] compared the effect of various stress media, under high light 
intensities, upon astaxanthin accumulation; those authors concluded that addition of CO2 in an N-free 
medium, under 546 μmolphoton m
−2 s
−1, were the best conditions for accumulation of astaxanthin—which 
attained ca. 30 mg g
−1. 
Astaxanthin  may  thus  be  efficiently  produced  outdoors  in  continuous  mode,  if  accurate  nitrate 
dosage is provided [48]; besides N, such oligoelements as iron play a role. This essential oligoelement 
takes part in assimilation of nitrate and nitrite, deoxidation of sulphate, fixation of N, and synthesis of 
chlorophyll [62–65]. Iron deficiency was reported to constrain microalga growth, even in rich nutrient 
media [64]; whereas its addition enhanced astaxanthin synthesis [66–69]. Cai et al. [67] further tested 
how  iron  electrovalencies  and  counter  ions  affect  cell  growth  and  accumulation  of  astaxanthin;  
18  μmol  L
−1  Fe
2+-EDTA  stimulated  synthesis  of  astaxanthin  more  effectively,  up  to  contents  of  
30.7 mg g
−1; and despite the lower cell density attained (2.3 ×  10
5 cell mL
−1), a higher concentration  
(36 μmol L
−1) of FeC6H5O7 yielded cell density and astaxanthin production levels that were 2- and  
7-fold those reached under iron-limitation.  
In the ―red stage‖ of growth, Haematococcus cells require only carbon as major nutrient—which 
this  is  usually  supplied  via  directly  injecting  CO2  into  the  photobioreactor  during  daylight
  [61]. 
Furthermore, high irradiance provides more energy for photosynthetic fixation of C, which leads to a 
higher rate of astaxanthin synthesis [68];
 this may be further enhanced by raising the C/N ratio
 [69]. Mar. Drugs 2011, 9                             
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Finally, Chen et al. [70] experimented with heterotrophic conditions—using pyruvate, citrate and 
malate  as  substrates,  towards  synthesis  of  astaxanthin  by  C.  zofingiensis  in  the  absence  of  light. 
Presence of any of the aforementioned substrates above 10 mM stimulated biosynthesis of astaxanthin 
(and other secondary carotenoids); ca. 100 mM pyruvate led to yields of 8.4–10.7 mg L
−1 astaxanthin, 
which correspond to a 28%-increase.  
5.3. β-Carotene  
Semicontinuous cultivation of D. salina at 25 ° C produced 80 g m
−3 d
−1 biomass [42]—from which 
1.25  mg  L
−1  of  β-carotene  was  recovered  [71];  however,  this  figure  could  be  improved  up  to  
2.45 mg m
−3 d
−1 in continuous biphasic bioreactors [72]. When cultivated photoheterotrophically, a 
significant increase of cellular β-carotene content was experimentally observed: the maximum score 
was 70 pg cell
−1, in a culture enriched with 67.5 mM acetate and 450 μM FeSO4 [33]. 
As with  astaxanthin,  Fe
2+ plays  an important  role in  β-carotene  accumulation in  D. salina;  by 
inducing oxidative stress, those cations stimulate said synthesis, especially in the presence of a carbon 
source. UV-A radiation (320–400 nm) added to the photosynthetically active radiation (PAR,  i.e.,  
400–700 nm) can be regarded as another stress factor during growth of, and carotenoid accumulation 
by Dunalliela bardawil; compared with cultures exposed to PAR only, addition of 8.7 W m
−2 UV-A 
radiation  to  250 W m
−2 PAR  stimulated long-term  growth of that  microalga,  and led to  a 2-fold 
enhancement in β-carotene accumulation by 24 d [38]. 
6. Extraction and Purification 
Although microalga-mediated synthesis  of carotenoids  is  crucial in  biotechnological  production 
thereof,  a  major  portion  (if  not  most)  of  their  cost  actually  lies  on  downstream  separation—e.g., 
biomass drying and disruption, followed by solvent extraction and purification. Hence, these issues are 
addressed below, in view of their importance toward commercial scale processes. 
6.1. Cell Disruption 
A major practical problem in using such microalgae as Murielopsis sp. or S. almeriensis is the need 
for cell wall disruption. This can be accomplished through a variety of ways, e.g., milling, ultrasound, 
microwave, freezing, thawing or chemical attack [45].  
The mortar-and-pestle procedure described by Mí nguez-Mosquera et al. [73] provides full recovery, 
but it cannot be scaled up to industrial practice; sonication and ball milling produce results similar to 
that  procedure,  as  long  as  alumina  is  employed  as  disaggregating  agent  [45].  Ceron  et  al.  [74] 
complemented the alumina-based cell disruption with alkaline treatment using 4% (w/v) aqueous KOH 
(40 ° C); disaggregation and lipid expression were both facilitated.  
6.2. Biomass Extraction  
Microalgal biomass is usually processed via solvent extraction, to render carotenoid extracts—with 
typical contents of 25% [45]; this can be used directly in the formulation of supplements, or undergo Mar. Drugs 2011, 9                             
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further multistep purification—encompassing hydrolysis to release hydroxylated carotenoids from the 
accompanying fatty acids, and final recrystallization to polish the product.  
Obtaining  a  carotenoid-rich  oleoresin  from  microalgae—dried  or  in  wet  paste  form,  is  a  more 
straightforward  task;  such  extracts  may  then  be  subjected  to  classical  processes  to  obtain  purer  
lutein [45,74] that may successfully compete with that extracted from marigold.  
6.2.1. Organic Solvent-Mediated Extraction  
Solvent extraction usually resorts to hexane—and has advantages over alkaline treatment because 
all lutein and zeaxanthin are converted to their free forms, while carboxylic acids and chlorophylls 
remain in the aqueous phase [45]; this method has been optimized for S. almeriensis [74]. Extraction 
was maximized with a 1:1 (v/v) ratio of hexane to sample, and the optimal number of extraction steps 
was  typically  six—which  led  to  95%  recovery  of  lutein.  Less  conventional  solvents—e.g.,  ethyl 
lactate, have been recently proposed [76] for plant matter at large, but can in principle be applied also 
to microalgae. 
A significant improvement would be to eliminate the drying step of microalgal biomass prior to 
extraction;  Ferná ndez-Sevilla  et  al.  [77]  have  accordingly  proposed  a  modification  of  a  previous 
approach  [74]  that  can  handle  wet  biomass  paste  (ca.  20%  DW),  based  on  an  extraction  phase 
composed by hexane/ethanol/water and KOH—which simultaneously effects an alkaline treatment to 
saponify susceptible lipids and extract the intended carotenoids.  
Another enhancement is the accelerated solvent extraction methodology, which uses a special type 
of contactor to circulate solvent at high pressure through a tightly packed bed of biomass. However, 
high temperatures are required (over 60 ° C, and usually as high as 170 ° C) to lower the viscosity of the 
solvent, which leads to formation of pheophorbide from the microalgal chlorophylls that are of a major 
toxicological concern. In any case, extraction with hexane or ethanol allows easy solvent removal 
afterwards, as well as high-content lutein extracts [45]. 
For selective extraction of free astaxanthin from red encysted Haematococcus sp., an alternative 
procedure  has  been  designed  that  resorts  to  dodecane  and  methanol  [75];  it  consists  of  
dodecane-mediated extraction of the crude mixture, followed by extraction with methanol. The first 
stage did not require previous cell harvesting, and separation of the dodecane-rich phase from the 
culture medium containing cell debris proceeded rapidly via plain settling. In the second stage, the free 
astaxanthin in the former extract was selectively solubilized in methanol along with saponification of 
astaxanthin esters—thus leading to a total recovery of astaxanthin above 85%.  
6.2.2. Green Solvent-Mediated Extraction 
An  environment-friendly  downstream  process  using  common  vegetable  oils  was  proposed  by  
Kang et al. [79] for direct extraction of astaxanthin from Haematococcus sp. As said crude microalgal 
astaxanthin consists of ca. 70% monoesters, 25% diesters and 5% free forms, a rather lipophilic nature 
results, so vigorous stirring is required to gradually disrupt the cells; the oily extracts are then simply 
separated from the culture medium containing cell debris by gravity settling. When using olive oil, 
recoveries of up to 93.9% were possible [79]. Apparently, a similar method had been proposed long 
before by Nonomura [80], who then claimed up to 7.5% yield of lutein. Mar. Drugs 2011, 9                             
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6.2.3. Supercritical Fluid-Mediated Extraction 
Classical extraction with organic solvents has attained purity degrees sufficient to meet commercial 
specifications for large-scale production of lutein; however, selective precipitation with supercritical 
CO2 constitutes a promising alternative. Note that conventional liquid extraction of carotenoids from 
microalgal matrices is time-consuming—as multiple extraction steps are typically required; and large 
relative ratios of organic solvents have to be used, which are often expensive and potentially harmful. 
Supercritical fluid extraction (SFE) using modified CO2 permits more straightforward purification and 
shorter extraction times [81]. 
In general, SFE is relatively rapid and efficient because of the low viscosities and high diffusivities 
that characterize supercritical  fluids.  Furthermore, extraction can be made selective by controlling 
solvent density; the material extracted will be recovered afterwards by simply depressurizing, thus 
allowing the supercritical fluid to return to its gaseous form and leaving no (or little) residual solvent 
in  the  precipitate  thus  originated
  [82].  Supercritical  CO2  has  so  far  been  the  most  employed 
supercritical fluid—because it is non-flammable, non-toxic, inexpensive and relatively inert from a 
chemical point of view. 
Previous studies demonstrated the feasibility of extracting pigments from plants using supercritical 
CO2—e.g., carotenoids from carrots [83] and cabbages [84]; Mendes et al. [85], Careri et al. [86] and 
Mací as-Sá nchez et al. [87–89] have meanwhile extended such a technique to extraction of carotenoids 
from C. vulgaris, Spirulina platensis, Nannochloropsis gaditana, Synechococcus sp. and S. almeriensis, 
respectively—and satisfactory results were consistently reported, as emphasized in Table 3. 
Table 3. SFE yields of total carotenoids (including lutein), and of lutein specifically, by 
selected microalgae. 
Microalga source 
Operating conditions 
(pressure/temperature/
time) 
Total 
carotenoids 
(mg/g DW biomass) 
Lutein 
(mg/g DW biomass) 
Total 
carotenoids/
Chlorophyll 
a ratio 
Reference 
Nannochloropsis 
gaditana 
200 bar/40 ° C/180 min  0.152  -  0.524 
[87] 
200 bar/50 ° C/180 min  0.152  -  0.410 
200 bar/60 ° C/180 min  0.125  -  1.389 
300 bar/40 ° C/180 min  0.208  -  0.258 
300 bar/50 ° C/180 min  0.248  -  0.230 
300 bar/60 ° C/180 min  0.250  -  0.179 
Chlorella vulgaris 
200 bar/40 ° C/198 min  0.011  -  - 
[85]  200 bar/55 ° C/180 min  0.008  -  - 
350 bar/55 ° C/252 min  0.080  -  - 
Synechococcus sp.
 
200 bar/40 ° C/180 min  0.386  -  193.000 
[88] 
200 bar/50 ° C/180 min  1.225  -  23.113 
200 bar/60 ° C/180 min  0.405  -  101.25 
300 bar/40 ° C/180 min  0.748  -  32.522 
300 bar/50 ° C/180 min  1.511  -  19.372 
300 bar/60 ° C/180 min  0.808  -  46.316 
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Table 3. Cont. 
Microalga source 
Operating conditions 
(pressure/temperature/
time) 
Total 
carotenoids 
 (mg/g DW biomass) 
Lutein 
(mg/g DW biomass)   
Total 
carotenoids/
Chlorophyll 
a ratio 
Reference 
Scenedesmus 
almeriensis  
200 bar/32 ° C/300 min  -  0.0013  - 
[89] 
200 bar/46 ° C/300 min  -  0.0000  - 
200 bar/60 ° C/300 min  -  0.0109  - 
300 bar/39 ° C/300 min  -  0.0236  - 
300 bar/53 ° C/300 min  -  0.0090  - 
However, this mode of extraction tends to recover chlorophylls more efficiently than carotenoids, 
thus producing extracts with relatively poor specifications [90]. Furthermore, the cost of supercritical 
fluids  and  associated  equipment  make  it  difficult  for  SFE  to  compete  with  classical  solvent  
extraction—especially because the former requires dry biomass. 
The selective adsorption of lutein might constitute an alternative in terms of separation/purification, 
especially if specific solid phases can be used [91], coupled with contacting conveyed by expanded 
beds [92]; this allows raw extracts to be processed, and tolerates the presence of cell debris or other 
particulate matter that causes major problems in conventional preparative chromatography. Selective 
precipitation was also described by Miguel et al. [93], who proposed use of supercritical CO2 after 
organic  solvent  extraction;  the  first  solvent  (containing  carotenoids)  was  accordingly  mixed  with 
supercritical  CO2,  and  the  conditions  of  pressure  and  temperature  were  duly  adjusted  to  promote 
preferential  precipitation  of  lutein.  However,  simple  standard  mixtures—rather  than  complex 
microalgal extracts have been considered, so a long way of improvement is still anticipated prior to 
practical use.  
6.2.4. In Situ Extraction 
In situ extraction of β-carotene from Dunaliella salina was recently reported by Kleinegris et al. [44], 
using a flat-panel photobioreactor operated as a turbidostat—where the numbers of stressed cells were 
kept essentially constant via a continuous, well-defined level of irradiation. This two-stage system 
comprised an organic phase of dodecane, sparged at a rate of 286 Ldodecane Lreactor
−1 min
−1 that promoted 
formation of an emulsion in the aqueous phase; β-carotene was then continuously extracted from the 
aqueous  to  the  organic  phase,  at  a  rate  of  ca.  2.75  mgβ-carotene  Ldodecane
−1  d
−1  (equivalent  to  
0.7  mgβ-carotene  Lreactor
−1  d
−1).  However,  this  process  exhibited  a  poor  efficiency—as  the  yield  of  
β-carotene  extracted  by  the  solvent  was  a  mere  one-tenth  of  that  removed  from  the  reactor  via  
biomass overflow.  
If the aforementioned carotenoid-rich biomass was extracted as well, then the overall volumetric 
productivity of the system would reach 8.3 mgβ-carotene Lreactor
−1 d
−1; this is still below the yield attained 
if downstream rather than in situ extraction was promoted (ca. 13.5 mgβ-carotene Lreactor
−1 d
−1) [44], so in 
this  system  simultaneous  biosynthesis  and  extraction  cannot  be  justified  relative  to  the  classical 
sequential approach.  
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7. Final Considerations 
Carotenoid production appears to be one of the most successful case studies of blue biotechnology. 
The rising market demand for pigments from natural sources has promoted large-scale cultivation of 
microalgae for synthesis of such compounds, so significant decreases in production costs are expected 
in coming years. 
The  recognized  therapeutic  value  of  some  carotenoids  (especially  lutein)  in  prevention  and 
treatment  of  degenerative  diseases  has  indeed  opened  new  avenues  for  development  of  mass 
production  systems.  Advances  in  knowledge  of  the  underlying  physiology,  biochemistry  and 
molecular genetics of carotenoid-producing microalgae are now urged—which would have a major 
impact upon development and optimization of this (and alternative) microalga-based technologies. In 
this regard, the genes encoding enzymes that are directly involved in specific carotenoid syntheses 
need in particular to be investigated—so that further development of transformation techniques will 
permit considerable increase of carotenoid cellular contents, and accordingly contribute to increase the 
volumetric productivities of the associated processes.  
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